Related Experiment Videos
Lipids in end-stage renal disease
1Department of Medicine, University of Würzburg, Germany. c.wanner@medizin.uni-wuerzburg.de
Journal of Nephrology
|May 23, 2002
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Epicardial fat, cardiovascular risk factors and calcifications in patients with chronic kidney disease.
Clinical kidney journal·2020
Short-Term Changes in Albuminuria and Risk of Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EMPA-REG OUTCOME Trial.
Journal of the American Heart Association·2020
Funding kidney research as a public health priority: challenges and opportunities.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2020
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
The New England journal of medicine·2020
Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus.
Scientific reports·2020
Predicting the Development of Anti-Drug Antibodies against Recombinant alpha-Galactosidase A in Male Patients with Classical Fabry Disease.
International journal of molecular sciences·2020
Medical student reliance on artificial intelligence in nephrology education.
Journal of nephrology·2026
<i>Clostridioides difficile</i> Infection-Associated Functional Bowel Disorder: A Three-Year Cohort Study.
Open forum infectious diseases·2026
Liver Iron Content in Individuals With B-Thalassemia Trait and Hyperferritinemia: Role of Metabolic Alterations, <i>HFE</i> Genotypes, and Cirrhosis.
Mediterranean journal of hematology and infectious diseases·2026